California · 2025–26 Regular Session · Assembly Bill
AB 577: Health care coverage: antisteering.
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
AB 577 is a assembly bill introduced in the California Assembly on February 12, 2025. According to its official title, it concerns: Health care coverage: antisteering. Primary sponsor: Lori Wilson (D). Most recent recorded action (February 2, 2026): From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Legislative Counsel’s Digest (official, as of the latest version). Written by nonpartisan legislative staff; reproduced verbatim.
Existing law provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes the willful violation of its provisions a crime. Existing law also provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health care service plan contract or health insurance policy that provides coverage for outpatient prescription drugs to cover medically necessary prescription drugs.
For a health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2026, this bill would prohibit a health care service plan, health insurer, or pharmacy benefit manager from engaging in specified steering practices, including, among others, requiring an enrollee or insured to use a retail pharmacy for dispensing prescription oral medications, as specified, and imposing any requirements, conditions, or exclusions that discriminate against an in-network physician in connection with dispensing prescription oral medications. The bill would require a health care provider, physician’s office, clinic, or infusion center to obtain consent from an enrollee or insured and disclose a good faith estimate of the enrollee’s or insured’s applicable cost-sharing amount before supplying or administering an injected or infused medication to an enrollee or insured, or sending an enrollee or insured to receive an injected or infused medication, if the setting or manner of administration is different than the setting or manner of administration for which the health care service plan, health insurer, or pharmacy benefit manager directed the enrollee or insured, as specified. Because a willful violation of these provisions relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Lori Wilson | Primary sponsor | Democratic | Assembly | 11 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
- Died pursuant to Art. IV, Sec. 10(c) of the Constitution.
- In committee: Set, second hearing. Held under submission.
- In committee: Hearing postponed by committee.
- In committee: Set, first hearing. Referred to suspense file.
- Re-referred to Com. on APPR.
- Read second time and amended.
- From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 12. Noes 0.) (April 29).
- Re-referred to Com. on HEALTH.
- From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
- Referred to Com. on HEALTH.
- From printer. May be heard in committee March 15.